Abstracts  / Posters / Presentations



Pan-American Congress of Rheumatology - PANLAR 2020

May 2 - 5, 2020 

Miami, FL


Paper Number: 369      Biomarker Levels Following Intravenous Belimumab in Childhood-Onset Systemic Lupus Erythematosus Support Beneficial Effects on Disease Activity: Results from the PLUTO study.                                              Poster Presentation: 




October 2019 - Accelerating Drug Development for Polyarticular Juvenile Idiopathic Arthritis (pJIA). View the speaker slides and video recordings.


April 2019 - FDA approves Benlysta (belimumab) for children with lupus who are five years old or above